✦ LIBER ✦
6004 ORAL Oblimersen plus fludarabine/cyclophosphamide (FC) significantly increases complete remission and overall survival in non-refractory patients (Pts) with relapsed chronic lymphocytic leukemia (CLL): results from a prospective randomized phase 3 trial
✍ Scribed by Novick, S.; O'Brien, S.; Moore, J.; Boyd, T.; Ding, L.; Rai, K.
- Book ID
- 122792151
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 62 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.